Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late. This story matters for Finance & Markets readers tracking trade. Reported by marketwatch.com. Read the full original at the source link below.
Originally reported by marketwatch.com. Trade-News curates and briefs the finance & markets stories that matter. Our editorial policy →